Pharmafile Logo
Pharmafocus logo
Advanced Search

HCMV

Showing 1 posts of 1 posts found.

Merck image

Merck enters €110m virus alliance

October 16, 2012
Research and Development, Sales and Marketing AiCuris, Gilead, HCMV, Merck

Merck has gained access to AiCuris’ portfolio of investigational medicines targeting human cytomegalovirus (HCMV) via a global licensing agreement. It …

News
The Gateway to Local Adoption Series

Latest content

START and Rome cancer institute partner to expand early-phase trial access in Italy

November 10, 2026

AbbVie expands Oxford R&D facility with new £120m UK research commitment

November 9, 2026

MedPharm appoints Jason Mieding as chief operating officer

November 8, 2026

UKRI backs five hubs developing AI tools for earlier disease detection

November 8, 2026

Coriolis Pharma appoints Teun van der Heide as CEO

November 7, 2026